Skip to content

CMR Exercise Stress Testing in HFpEF

Cardiovascular Magnetic Resonance Real-time Exercise Stress Testing in Heart Failure With Preserved Ejection Fraction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03260621
Acronym
HFpEF-Stress
Enrollment
75
Registered
2017-08-24
Start date
2017-08-16
Completion date
2020-09-01
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diastolic Heart Failure

Brief summary

Patients of the University Hospital Göttingen with echocardiographic signs for diastolic heart failure and indication for right heart catheterisation will undergo additional diagnostic testing with CMR including exercise stress for detailed evaluation of diastolic dysfunction and tissue characterisation correlating the results with well-established clinical standards.

Interventions

DIAGNOSTIC_TESTstress CMR

additional stress CMR to the established clinical diagnostics

Sponsors

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
CollaboratorOTHER
University of Göttingen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients with dyspnoea under stress, echocardiographic criteria for diastolic dysfunction (E/E'\>8) and clinical indication for right heart catheterisation

Exclusion criteria

* arrhythmia (brady- or tachycardic) * bronchial asthma (allergic) * incompliant patient * pacemaker, ICD, non MRI-capable devices * inability to use the ergometer in the MRI * haemodynamic relevant valvular heart disease * pulmonary disease (vital capacity or forced expiratory flow \<80% of healthy control) * angina pectoris * post cardiac infarction * anaemia (Hb \<12 g/dl) * uncontrollable hypertension (\>150 mmHg systolic or \>100 mmHg diastolic) * age \<18 years * pregnancy * claustrophobia * renal insufficiency * allergic to gadolinium based contrast agents

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular magnetic resonance imagingapprox. 1 yearsventricular and atrial volumes

Other

MeasureTime frameDescription
Exercise spirometryapprox. 1 yearsmaximal oxygen uptake
Right heart catheterizationapprox. 1 yearsreference for intracardiac pressures: pulmonary artery pressure and pulmonary capillary wedge pressure

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026